Greene John insider trades
Greene John has filed 22 Form 4s with the SEC that we hold, for DFS (EVP, Chief Financial Officer), CRISPR Therapeutics AG (CRSP) (Director) and Northrop Grumman Corp /DE/ (NOC) (CVP & Chief Financial Officer). Across all of them we count 1 purchase worth $313.9K and 2 sales worth $4.3M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 35,191 shares of DFS worth $3.7M, dated 2024-01-26. The first filing on our record is dated 2021-08-03 and the latest 2026-06-09.
DFS
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-02-15 | S, sale reported on Form 4 | 4,443 | $568.5K | 2022-02-17 |
| 2024-01-26 | S, sale reported on Form 4 | 35,191 | $3.7M | 2024-01-30 |
CRISPR Therapeutics AG (CRSP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-02-26 | P, purchase reported on Form 4 | 7,000 | $313.9K | 2025-02-28 |
Northrop Grumman Corp /DE/ (NOC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1610732) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms